Design and rationale for the targeted intra-renal fenoldopam for avoidance of nephropathy (TIFFANY) trial 17th Annual Transcatheter Cardiovascular Therapeutics Symposium/4th Annual Transcatheter Cardiovascular Therapeutics Inflammation Summit Price, M. J., Garcia, L., Davidson, C., McNeil, J., Cohen, M. G., Mathur, V., Fearon, W. F., Weisz, G., Rogers, C., Madyoon, H., Feit, F., Low, R., Reisman, M., Teirstein, P. S. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC. 2005: 117H–117H

View details for Web of Science ID 000232725200287